Efficacy of Olanzapine-Triple Antiemetic Regimen in Patients with Gastrointestinal Tumor and High Risk of Chemotherapy-Induced Nausea and Vomiting Receiving Moderately Emetogenic Chemotherapy: A Retrospective Study

PURPOSE: Dexamethasone combined with 5-hydroxytryptamine type 3 receptor antagonists (5-HT3 RA) dual regimen is the standard prophylaxis regimen for patients receiving moderately emetogenic chemotherapy (MEC). However, it has been found in real-world practice that chemotherapy-induced nausea and vom...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Xuan, Wu, Jingxun, Tong, Gangling, Cheng, Boran, Chen, Minhua, Yu, Shaokang, He, Lirui, Li, Zhu, Wang, Shubin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402666/
https://www.ncbi.nlm.nih.gov/pubmed/32801895
http://dx.doi.org/10.2147/CMAR.S254398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402666/
https://www.ncbi.nlm.nih.gov/pubmed/32801895
http://dx.doi.org/10.2147/CMAR.S254398

Ejemplares similares